HALIFAX, Oct. 17, 2018 /PRNewswire/ – Adaptiiv Medical Technologies Inc. (Adaptiiv), an innovative medical technology company, announced today the release of a proprietary AccuCALC© that allows cancer centers to determine the business case for offering 3D Bolus, Adaptiiv’s advanced software solution. The AccuCALC© was developed by Churchill Consulting, a division of Crux Quality Solutions (www.cruxqs.com) which provides consulting and integrated system solutions to radiation therapy departments, freestanding facilities and professional practices.
“We have seen significant demand from our clients for information pertaining to 3D Bolus, Adaptiiv’s solution that enables the creation of customized 3D personal medical devices using 3D printing, used primarily in the treatment of cancer,” said Jordan Johnson, Director of Compliance at Churchill Consulting. “Yet as is common with many leading-edge technologies, our clients are unsure of whether they can bill for a new technology or its potential return on investment. AccuCALC© addresses that problem.”